🚀 Business & Startups🌐 Global
Eli Lilly's Next-Gen Weight-Loss Drug Clears Major Heart Safety Hurdle
mint - companies·Friday, 24 July 2026
Eli Lilly announced that its next-generation weight-loss injection did not increase overall heart risk in a new study, addressing a key concern ahead of regulatory review. The result strengthens the drug's case as it moves closer to approval.
Why It Matters
Obesity and related heart disease are rising health crises in India too. New weight-loss drugs that clear safety tests could eventually reach Indian patients and reshape how doctors treat obesity.
🔒 Potential Impact + source link
Subscribe to unlock the impact analysis and original source for every story.